Global Precision Medicine Market Report

September 22, 2017

Coherent Market Insights 

“Advancements in genomics and big data analytics are driving growth in the precision medicine market: Next-generation sequencing and genomic profiling technologies have advanced significantly in recent years, enabling better detection and understanding of diseases at the molecular level.”

 

The precision medicine market is projected to reach USD 92.31 billion by 2024, driven by innovations like FDNA’s Face2Gene platform. Face2Gene leverages artificial intelligence and deep learning to analyze facial features, aiding in the accurate expedited diagnosis of genetic disorders. This technology exemplifies the growing impact of AI in precision medicine, enabling personalized treatment plans based on individual genetic profiles. The market expansion reflects an increasing demand for tailored healthcare solutions and advanced decision support tools, underscoring the critical role of platforms like Face2Gene in revolutionizing patient care and improving health outcomes globally.

Related articles

Dr. Bruno

The Importance of Teaching Face2Gene to Pediatricians

In the world of rare genetic diseases, early diagnosis is often the key to better patient outcomes. However, the diagnostic journey can be long and complex, sometimes taking years before a definitive answer is found. Dr. Bruno Bordest, a Brazilian geneticist who teaches at the Universidade Federal de Mato Grosso, has been working to bridge […]

Continue reading
AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading